Clinical Trial: Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer

Clinical Trial: Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer

Sponsor and Collaborators

University of Lausanne Hospitals
Advanced Accelerator Applications
Centre d'Imagerie Biomédicale (CIBM), Lausanne, Switzerland

Contact
Contact: John O Prior, PhD MD
+41 21 314 4348
john.prior@chuv.ch

Contact: Jean-Yves Meuwly, MD
+41 21 314 4395
jean-yves.meuwly@chuv.ch

ClinicalTrials.gov Identifier

NCT00963755
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs